
Mayo Clinic , just extended its foreign footprints by opening its first business in , China.
In June,  , Mayo Clinic , opened an international official company on the school of , United Family Healthcare , in the Jing’an city in , Shanghai.
Dr.  , Stacey Rizza,  , Mayo Clinic ‘s , administrative clinical director of the , Asia-Pacific place, explained the purpose of the new business.
The company joins many others created around the world to provide assistance to people who are interested in interacting with the Mayo Clinic. The , Shanghai , department staff, proficient in Mandarin and English, will help people, their people and doctors who refer people to make visits at , Mayo Clinic , in , Rochester, Minnesota,  , Phoenix , and , Scottsdale, Arizona,  , Jacksonville, Florida, and , Mayo Clinic Healthcare , in , London”, she wrote.
The office, which does not offer medical care, works with families, referring physicians, health insurance providers and insurance brokers.
Staff in the , Shanghai , office assist patients with travel, lodging, billing and insurance arrangements, provide general orientation to , Mayo Clinic, facilitate Mayo review of medical records, and coordinate future appointments. They also help to connect referring physicians and insurers with , Mayo Clinic.
While this is the first in , China,  , Mayo Clinic , has similar international patient offices in , Canada,  , Colombia, the , Dominican Republic,  , Ecuador,  , El Salvador,  , Guatemala,  , Honduras,  , India,  , Indonesia,  , Mexico,  , Panama,  , Peru, the , United Arab Emirates, the , United Kingdom , and , Uruguay.
” The offices are part of , Mayo Clinic ‘s , work to provide a seamless patient experience and serve as a resource for patients”, wrote Rizza.
When asked if , Mayo Clinic , was considering opening a hospital or clinic in , China , as it did in , London , in 2019, Rizza answered no.
Mayo Clinic, which treated more than 1.3 million patients from more than 130 countries in 2023, has long had an interest in , China.
In 2015,  , Mayo Clinic , and , Hong Kong-based , Medisun Holdings Ltd.  , signed a collaborative deal to “ensure efficient referral of patients” to , Mayo Clinic. That endeavor came to an end in 2018.
In early 2018,  , Mayo Clinic , partnered with the , WuXi AppTec Group , to launch a joint venture called , WuXi Diagnostics. The joint venture aimed to “develop advanced diagnostic technologies to create a world-leading clinical special diagnostic platform, integrated research and development of clinical diagnostic reagents and products platform, establish a comprehensive large-scale clinical testing data center, and empower Chinese medical institutions.”
WuXi Diagnostics , opened a “research and diagnostic testing development facility” in the , One Discovery Square , complex in downtown , Rochester , in 2019.  , Mayo Clinic , described the lab as , WuXi Diagnostics ‘ , first , U. S. based research and diagnostic testing development facility. It has since closed.
In February,  , WuXi AppTec , was flagged by the , U. S. House Select Committee on , the , Strategic Competition , between , the United States , on a list of “foreign adversary” with reported ties to , the People’s Republic of China ‘s , military. Rizza stated that the Mayo/WuXi AppTec , venture concluded “earlier this year”.
___
( c ) 2024 the Post-Bulletin
Distributed by , Tribune Content Agency, LLC.